secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtaiBeckley Inc. (ATAI)
CIK:        0002081043
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001140361-26-006880
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AtaiBeckley reports positive Phase 2a results for EMP-01 in Social Anxiety Disorder; LSAS -11.85 vs placebo
--------------------------------------------------------------------------------

- EMP-01 met primary safety objective; no serious AEs, no suicidal behavior.
- LSAS placebo-adjusted reduction of 11.85 points at Day 43 (Hedges' g=0.45, p=0.036 one-tailed).
- CGI-I responders: 49% EMP-01 vs 15% placebo; NNT 2.95.
- Improvements in both Fear (-13.7) and Avoidance (-15.1) subscales after two doses without psychotherapy.
- 71 patients enrolled, 69 completed Day 43 with high retention.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2081043/000114036126006880/0001140361-26-006880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2081043/000114036126006880/ef20066456_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-006880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer